Gut Microbiota Metabolites and Coronary Heart Disease in ARIC and MESA Cohorts

In-silico validation data for associations between circulating gut microbiota-related metabolites and incident coronary heart disease. The dataset was created by Yulu Zheng and last updated on March 17, 2026. It is a 33.8 KB XLSX file with an open CC-BY-4.0 license.

Use Cases

• Validate associations between specific microbial metabolites and coronary heart disease risk based on the study's findings.
• Investigate potential effect modifications by factors like metabolic disease history or body mass index as suggested by the description.
• Perform secondary analysis on the five significantly associated metabolites highlighted in the original research.

Strengths

• Data is from two established cohorts, ARIC and MESA, which suggests a multi-source validation approach.
• The 33.8 KB file size indicates a focused dataset likely containing summary statistics or key results.
• The CC-BY-4.0 license allows for open sharing and reuse.

Limitations

• Row count and column-level documentation are unknown, limiting suitability assessment.
• The description is brief; detailed methodology and variable definitions require inspection after download.

Provenance

Source

Yulu Zheng via figshare.

Collection Method

In-silico validation study using data from the ARIC and MESA cohorts.

Freshness

Last updated 2026-03-17 17:42:02.

Geography

Data likely originates from the United States, given the ARIC and MESA cohort studies.